IKBKB and B-cell chronic lymphocytic leukemia: Using a selective NIK inhibitor, CW15337 (Ki = 25 nM), with no inhibitory effects on IKKα or IKKβ at these concentrations [25], we showed that primary CLL cells as well as CLL and MM cell lines were all sensitive to the effects of NIK inhibition.